DEERFIELD, Ill., and BOSTON, Mass., February 25, 2008 — Today at the 2008 Healthcare Information and Management Systems Society (HIMSS) meeting, Baxter Healthcare Corporation and Capsule announced a collaboration that allows Baxter to leverage Capsule’s DataCaptor™ Connectivity Suite with Baxter’s COLLEAGUE Volumetric infusion pumps. This agreement will provide Baxter with a wired and wireless connectivity solution that can connect the COLLEAGUE pump to many healthcare information systems.
This connectivity solution will allow for the rapid transfer of data between the infusion pumps and the hospital’s existing information infrastructure. The infusion data may be integrated for various clinical systems to aid in improving safety, workflow and reducing medication errors.
“Directly connecting COLLEAGUE pumps with other hospital technologies may help to reduce medication errors and improve patient safety,” said Camille Farhat, general manager of Global Infusion Systems, part of Baxter’s Medication Delivery business. “This relationship with Capsule fits into our vision to continuously improve patient care through safe, effective and innovative medication delivery solutions.”
“We are thrilled to partner with such an important healthcare organization and leading expert in medical devices,” said Arnaud Houette, president and CEO of Capsule. “Baxter understands the value of providing automated data connectivity between their infusion pumps and clinical information systems. Our DataCaptor Connectivity Suite will help to provide our mutual customers improved patient care and clinician efficiency by reducing the risk of documentation errors that are inherent in manual data entry.”
The new DataCaptor connectivity solution provides a standard interface to send infusion data from COLLEAGUE pumps to the hospital’s healthcare information system. Clinicians can then utilize these data within their hospital information system to support increased efficiency and patient safety.
About Medication Delivery For more than 75 years, Baxter has pioneered products designed to help reduce errors throughout the medication management process by improving the interface between technology and clinicians. For example, to help prevent accidental needle-stick injuries, Baxter introduced the industry’s first “needleless” IV access system.
Most recently, the company introduced the first needleless IV connector containing an antimicrobial coating, V-Link Luer-activated device (LAD) with VitalShield protective coating. Later this year, Baxter plans to introduce a new integrated portfolio of infusion pumps and administration sets, designed to promote increased security and confidence in delivery of IV medications.
About Baxter Baxter Healthcare Corporation is the principal U.S. operating subsidiary of Baxter International Inc. (NYSE:BAX). Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including cancer, hemophilia, immune disorders, kidney disease and trauma. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients’ lives.
About Capsule Capsule is the world’s leading, award-winning provider of solutions for medical device data integration. Founded in 1997, the company has established market leadership through its suite of hardware and software products, its unique expertise in device protocols and firmware, and through its strong partnerships with major medical device manufacturers and healthcare information technology companies. In 2007 and 2008, Frost & Sullivan recognized Capsule’s contribution and honored the company with the Enabling Technology Award in the Patient Monitoring Industry for Medical Device connectivity Excellence. Deloitte also acknowledged Capsule for its stellar revenue growth and presented the company with the Deloitte Technology Fast 50 and Fast 500 EMEA Awards. For more information, please check the company’s Web site at http://www.capsuletech.com/ or contact the Company’s U.S. Marketing & Public Relations at 503-352-3808.
This release includes forward-looking statements concerning the collaboration between Baxter Healthcare Corporation and CapsuleTech, Inc. and/or its affiliates regarding wired and wireless connectivity solutions for Baxter’s COLLEAGUE infusion pump platform, including statements with respect to the integration of infusion data into various clinical systems, the reduction of medication errors and documentation errors, the improvement of patient safety and statements regarding the introduction by Baxter of new products. These statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: the ability to successfully interface the DataCaptor Connectivity Suite to the COLLEAGUE infusion pump platform; Capsule’s ability to successfully integrate the connectivity solution with Baxter’s customer’s various clinical systems; customer and market acceptance of the connectivity solution and other new Baxter products; Baxter’s ability to successfully introduce a new integrated portfolio of infusion pumps and administration sets; clinician practices and procedures; future actions by FDA and other regulatory bodies and government authorities with respect to Baxter’s infusion pumps and other new Baxter products; and other risks identified in Baxter International Inc.’s most recent filing on Form 10-Q and other SEC filings, all of which are available on Baxter International Inc.’s website. Baxter does not undertake to update its forward-looking statements.
